drugset / Trial / NCT00504127
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To study of efficacy and safety of Naproxcinod vs. Naproxen and Placebo in the indication of signs and symptoms of osteoarthritis
Timeline
- Start
- 2007-04
- Primary completion
- 2008-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | 500 mg | — |
| Subject | naproxcinod | Other / unclassified | 375 mg | — |
| Subject | naproxcinod | Other / unclassified | 750 mg | — |